| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |